Aprea Therapeutics (NASDAQ:APRE – Get Free Report) announced its quarterly earnings results on Wednesday. Aprea Therapeutics had a negative net margin of 4,405.59% and a negative return on equity of 61.03%. Aprea Therapeutics Price PerformanceNASDAQ APRE traded up $0.02 during trading on Wednesday, hitting $0.68. Institutional Investors Weigh In On Aprea TherapeuticsAn institutional investor recently bought a new position in Aprea Therapeutics stock. Jane Street Group LLC owned about 0.67% of Aprea Therapeutics as of its most recent filing with the Securities & Exchange Commission.